Evaluation of combinations of antineoplastic ether phospholipids and chemotherapeutic drugs.
Combinations of drugs are used clinically for the therapeutic advantages they may provide over single agents. We have studied the cytotoxic interaction between four either phospholipids ET-18-OCH3, BM 41.440, BN 52205 and BN 52211, and several chemotherapeutic drugs (ADM, CDDP, VLB, VP-16, MMC, BLM and MTX) on two human tumor cell lines, A427 (lung) and HT29 (colon). We have used the MTT colorimetric assay to evaluate growth inhibition and performed isobologram analysis on the IC50 data. For both cell lines a synergistic effect has been found between each of the four ether phospholipids in association with CDDP and ADM. In both cell lines only BM 41.440 and BN 52211 act synergistically with VLB while, in A427 cells, only BN 52205 behaves similarly with MMC. These results show that a positive interaction exists between ether phospholipids, spindle poisons and DNA-interactive drugs.
Principe
P
P
Institut Henri Beaufour, Les Ulis, France.
Coulomb
H
H
Broquet
C
C
Braquet
P
P
D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage*; D002470:Cell Survival / Q000187:drug effects; D003124:Colorimetry; D004354:Drug Screening Assays, Antitumor; D004357:Drug Synergism; D006801:Humans; D009580:Nitroblue Tetrazolium; D010742:Phospholipid Ethers / Q000008:administration & dosage*; D014407:Tumor Cells, Cultured / Q000187:drug effects* / Q000473:pathology
D010742:Phospholipid Ethers; D009580:Nitroblue Tetrazolium